1. Home
  2. COOK vs AVXL Comparison

COOK vs AVXL Comparison

Compare COOK & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COOK
  • AVXL
  • Stock Information
  • Founded
  • COOK 1985
  • AVXL 2004
  • Country
  • COOK United States
  • AVXL United States
  • Employees
  • COOK N/A
  • AVXL N/A
  • Industry
  • COOK Wholesale Distributors
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • COOK Consumer Discretionary
  • AVXL Health Care
  • Exchange
  • COOK Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • COOK 406.5M
  • AVXL 484.2M
  • IPO Year
  • COOK 2021
  • AVXL N/A
  • Fundamental
  • Price
  • COOK $2.98
  • AVXL $7.45
  • Analyst Decision
  • COOK Buy
  • AVXL Strong Buy
  • Analyst Count
  • COOK 7
  • AVXL 2
  • Target Price
  • COOK $3.83
  • AVXL $43.00
  • AVG Volume (30 Days)
  • COOK 159.0K
  • AVXL 1.6M
  • Earning Date
  • COOK 11-06-2024
  • AVXL 11-25-2024
  • Dividend Yield
  • COOK N/A
  • AVXL N/A
  • EPS Growth
  • COOK N/A
  • AVXL N/A
  • EPS
  • COOK N/A
  • AVXL N/A
  • Revenue
  • COOK $598,914,000.00
  • AVXL N/A
  • Revenue This Year
  • COOK $0.97
  • AVXL N/A
  • Revenue Next Year
  • COOK $4.69
  • AVXL N/A
  • P/E Ratio
  • COOK N/A
  • AVXL N/A
  • Revenue Growth
  • COOK 3.17
  • AVXL N/A
  • 52 Week Low
  • COOK $1.97
  • AVXL $3.25
  • 52 Week High
  • COOK $3.97
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • COOK 39.96
  • AVXL 54.68
  • Support Level
  • COOK $2.91
  • AVXL $7.55
  • Resistance Level
  • COOK $3.59
  • AVXL $10.45
  • Average True Range (ATR)
  • COOK 0.16
  • AVXL 0.84
  • MACD
  • COOK -0.01
  • AVXL 0.08
  • Stochastic Oscillator
  • COOK 9.56
  • AVXL 37.77

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: